Donald E Wesson Selected Research

Citric Acid (Citrate)

1/2019	Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis.
1/2019	Urine citrate excretion identifies changes in acid retention as eGFR declines in patients with chronic kidney disease.
9/2012	Acid-base status and progression of chronic kidney disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Donald E Wesson Research Topics

Disease

32	Acidosis 02/2024 - 04/2010
30	Chronic Renal Insufficiency 02/2024 - 03/2006
8	Chronic Kidney Failure (Chronic Renal Failure) 01/2024 - 11/2006
6	Kidney Diseases (Kidney Disease) 01/2023 - 11/2012
5	Renal Insufficiency (Renal Failure) 01/2024 - 12/2010
5	Hypertension (High Blood Pressure) 01/2022 - 03/2006
4	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 03/2006
4	Albuminuria 08/2014 - 01/2003
4	Hypertensive Nephropathy 03/2013 - 04/2010
3	Essential Hypertension 01/2017 - 09/2005
2	Fibrosis (Cirrhosis) 01/2020 - 03/2014
2	Inflammation (Inflammations) 01/2020 - 03/2014
2	Disease Progression 01/2020 - 04/2019
2	Cysts 01/2017 - 01/2016
2	Polycystic Kidney Diseases (Polycystic Kidney Disease) 01/2017 - 01/2016
2	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2017 - 01/2016
2	Type 2 Diabetes Mellitus (MODY) 02/2004 - 01/2003
1	Kidney Calculi (Kidney Stone) 07/2023
1	Hyperkalemia 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Uremia 01/2020
1	Bone Resorption 04/2019
1	Flatulence 04/2019
1	Nausea 04/2019
1	Constipation 04/2019
1	Frailty 01/2019
1	Anemia 08/2014
1	Sickle Cell Anemia (Hemoglobin S Disease) 08/2014
1	Vascular Diseases (Vascular Disease) 08/2014
1	Hypoxia (Hypoxemia) 02/2012
1	Hyperoxia 01/2004
1	Ischemia 01/2004
1	Diabetic Nephropathies (Diabetic Nephropathy) 02/2002

Drug/Important Bio-Agent (IBA)

37	AcidsIBA 02/2024 - 05/2009
18	Bicarbonates (Hydrogen Carbonate)IBA 02/2024 - 08/2010
11	AlkaliesIBA 01/2021 - 12/2010
7	Sodium Bicarbonate (Baking Soda)FDA LinkGeneric 04/2019 - 08/2010
7	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2017 - 02/2002
6	veverimerIBA 01/2024 - 01/2019
6	AlbuminsIBA 12/2023 - 01/2003
6	CreatinineIBA 12/2023 - 01/2003
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 11/2012
5	Hydrochloric Acid (Hydrogen Chloride)FDA Link 03/2024 - 04/2019
5	Angiotensin IIIBA 01/2022 - 12/2012
4	AldosteroneIBA 01/2020 - 12/2010
4	Endothelins (Endothelin)IBA 03/2014 - 04/2010
3	Citric Acid (Citrate)FDA LinkGeneric 01/2019 - 09/2012
2	LipidsIBA 01/2022 - 11/2015
2	Muscle Proteins (Muscle Protein)IBA 01/2022 - 01/2022
2	PolymersIBA 01/2022 - 01/2022
2	SodiumIBA 01/2019 - 01/2017
2	dioxotechnetiumIBA 01/2019 - 11/2014
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2003 - 02/2002
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	sodium zirconium cyclosilicateIBA 01/2021
1	Endothelin-1 (Endothelin 1)IBA 01/2020
1	AmmoniaIBA 01/2020
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2020
1	Hormones (Hormone)IBA 01/2020
1	Serum AlbuminIBA 01/2019
1	SuspensionsIBA 01/2019
1	Dietary SodiumIBA 01/2017
1	Urea (Carbamide)FDA LinkGeneric 01/2017
1	SaltsIBA 01/2016
1	AngiotensinogenIBA 11/2014
1	Oxygen (Dioxygen)IBA 08/2014
1	Erythropoietin FDA Link 02/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2012
1	Transforming Growth Factor beta (TGF-beta)IBA 02/2012
1	NF-kappa B (NF-kB)IBA 02/2012
1	Dietary ProteinsIBA 01/2012
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 04/2011
1	Mineralocorticoid Receptor AntagonistsIBA 12/2010
1	Sodium Chloride FDA LinkGeneric 08/2010
1	Antihypertensive Agents (Antihypertensives)IBA 08/2010
1	Hemoglobins (Hemoglobin)IBA 11/2006
1	Scavenger Receptors (Scavenger Receptor)IBA 11/2006
1	8-epi-prostaglandin F2alphaIBA 11/2006
1	ProstaglandinsIBA 11/2006
1	IsoprostanesIBA 11/2006
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2004
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2004

Therapy/Procedure

7	Therapeutics 04/2019 - 02/2004
5	Nephrectomy 01/2019 - 12/2010
2	Kidney Transplantation 01/2024 - 01/2019
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2023 - 03/2020